<i>TGFBI</i> Promoter Methylation is Associated with Poor Prognosis in Lung Adenocarcinoma Patients.

Mol Cells · 2019 · PMC6399005 · PMID 30726660

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

borderline significanceP = 0.06so close (0.05 < p ≤ 0.1)

Association of TGFBI methylation with clinicopathological parameters and clinical outcomes Our results showed that TGFBI methylation was more frequent in patients with lymph node metastasis than in those without metastasis with a borderline significance (28.6% vs 14.6%, P = 0.06) ( Table 1 ).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.